Age and the association between apolipoprotein E genotype and Alzheimer disease: a cerebrospinal fluid biomarker–based case–control study

Keyphrases

• Alzheimer's Disease 100%
• Cerebrospinal Fluid 100%
• Apolipoprotein E 100%
• Odds Ratio 23%
• Dementia 15%
• Risk Factors 15%
• Alzheimer's Disease Diagnosis 15%
• Population Attributable Fraction 15%
• Disease Case 15%
• Disease-associated 7%
• Population Control 7%
• Neurodegeneration 7%
• Diagnostic Criteria 7%
• Total tau 7%
• Phosphorylated tau 7%
• Confidence Interval 7%
• Gene Age 7%
• Disease-based 7%
• Homozygote 7%
• Criteria-based 7%
• Clinical Symptoms 7%
• Control Population 7%
• Protective Effect 7%
• Age Groups 7%
• Pathologic 7%
• Early Intervention 7%
• Memory Centers 7%
• Increasing Age 7%
• Fluid Level 7%
• Population Level 7%
• Age-specific 7%
• Age Categories 7%
• Longitudinal Cohort Study 7%
• Incident Cases 7%
• Free Control 7%
• Abnormal Value 7%
• Carrier Status 7%
• Amyloid-β Peptide 7%
• N Classification 7%
• Alzheimer's Disease Pathology 7%
• Amyloid Deposition 7%
• Alzheimer's Disease Neuroimaging Initiative 7%
• Dementia Prevention 7%
• Cerebrospinal Fluid Biomarkers 7%
• European Memory 7%
• Whitehall II 7%
• Disease Criteria 7%
• Three-City 7%
• White People 7%
• Memory Clinic 7%
• Unadjusted Analyses 7%

Biochemistry, Genetics and Molecular Biology

• Liquid 100%
• Genotyping 100%
• Apolipoprotein E 100%
• Allele 50%
• Tau 37%
• Amyloid Protein 25%
• Genetic Carrier 12%
• Cohort Study 12%
• Population 12%
• Homozygote 12%
• Heterozygote 12%
• Cerebrospinal Fluid Level 12%
• Abnormal Value 12%
• Population Dynamics 12%

Neuroscience

• Apolipoprotein E 100%
• Alzheimer's Disease 100%
• Amyloid Protein 11%
• Neurodegeneration 5%